Repligen | RGEN - Interest Expense On Debt

Stock Price
136.44
Daily Change
3.81 2.87%
Monthly
-15.79%
Yearly
-7.13%
Q1 Forecast
137.82

Repligen reported $5.41M in Interest Expense on Debt for its fiscal quarter ending in September of 2025.





Interest Expense On Debt Change Date
Agilent USD 27M 1000K Sep/2025
Align Technology USD 2M 660K Mar/2023
Bio Techne USD 2.18M 173K Jun/2025
BioMarin Pharmaceutical USD 2.58M 100K Sep/2025
Bristol-Myers Squibb USD 432M 48M Dec/2025
Bruker USD 20M 4.3M Sep/2025
Charles River Laboratories USD 25.4M 4.56M Sep/2025
Danaher USD 55M 12M Dec/2025
Dentsply International USD 23M 1000K Sep/2025
Exact Sciences USD 9.79M 46K Sep/2025
General Electric Aerospace USD 496M 271M Dec/2025
Henry Schein USD 38M 0 Sep/2025
Illumina USD 25M 0 Sep/2025
IQVIA Holdings USD 193M 4M Dec/2025
Mettler Toledo International USD 17.39M 307K Dec/2025
Myriad Genetics USD 800K 100K Mar/2025
OraSure Technologies 2.91M 130K Dec/2024
Pacific Biosciences Of California USD 3.54M 0 Sep/2024
Pfizer USD 711M 59M Dec/2025
Repligen USD 5.41M 60K Sep/2025
Revvity USD 23.51M 742K Dec/2025
Standard Biotools USD 10K 1000 Sep/2025
Thermo Fisher Scientific USD 365M 18M Dec/2025
Waters USD 8.62M 18.02M Dec/2025
West Pharmaceutical Services USD 200K 100K Sep/2025